The only way to manage neurodegeneration in MS is to prevent it with effective anti-inflammatory therapy: No.
- Published in:
- Multiple Sclerosis Journal, 2012, v. 18, n. 12, p. 1682, doi. 10.1177/1352458512464406
- By:
- Publication type:
- Article
Works matching IS 13524585 AND DT 2012 AND VI 18 AND IP 12
Results: 25
1
2
Commentary on ‘Disability outcome measures in multiple sclerosis clinical trials’.
- Published in:
- 2012
- By:
- Publication type:
- Opinion
3
The only way to manage neurodegeneration in MS is to prevent it with effective anti-inflammatory therapy: Commentary.
- Published in:
- 2012
- By:
- Publication type:
- Opinion
4
Intramuscular interferon beta-1a is effective in Japanese patients with relapsing–remitting multiple sclerosis: a pre-treatment versus treatment comparison study of gadolinium-enhanced MRI brain lesions.
- Published in:
- Multiple Sclerosis Journal, 2012, v. 18, n. 12, p. 1782, doi. 10.1177/1352458512442261
- By:
- Publication type:
- Article
5
The only way to manage neurodegeneration in MS is to prevent it with effective anti-inflammatory therapy: Yes.
- Published in:
- Multiple Sclerosis Journal, 2012, v. 18, n. 12, p. 1680, doi. 10.1177/1352458512464687
- By:
- Publication type:
- Article
6
HERVs: have we been here before?
- Published in:
- 2012
- By:
- Publication type:
- Editorial
7
Karl Vass, 1958–2012.
- Published in:
- 2012
- By:
- Publication type:
- Obituary
8
LACTRIMS Abstracts.
- Published in:
- 2012
- Publication type:
- Abstract
9
Plenary Session.
- Published in:
- 2012
- Publication type:
- Abstract
10
Evaluating cognitive outcome measures for MS clinical trials: what is a clinically meaningful change?
- Published in:
- Multiple Sclerosis Journal, 2012, v. 18, n. 12, p. 1673, doi. 10.1177/1352458512454774
- By:
- Publication type:
- Article
11
Quality of life reporting in multiple sclerosis clinical trials: enough quality?
- Published in:
- 2012
- By:
- Publication type:
- Editorial
12
Non-lesional white matter changes in pediatric multiple sclerosis and monophasic demyelinating disorders.
- Published in:
- Multiple Sclerosis Journal, 2012, v. 18, n. 12, p. 1754, doi. 10.1177/1352458512447527
- By:
- Publication type:
- Article
13
Natalizumab strongly suppresses cortical pathology in relapsing–remitting multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2012, v. 18, n. 12, p. 1760, doi. 10.1177/1352458512447704
- By:
- Publication type:
- Article
14
Cutaneous adverse events associated with disease-modifying treatment in multiple sclerosis: a systematic review.
- Published in:
- Multiple Sclerosis Journal, 2012, v. 18, n. 12, p. 1705, doi. 10.1177/1352458512438239
- By:
- Publication type:
- Article
15
Prevalence of anti-drug antibodies against interferon beta has decreased since routine analysis of neutralizing antibodies became clinical practice.
- Published in:
- Multiple Sclerosis Journal, 2012, v. 18, n. 12, p. 1775, doi. 10.1177/1352458512446036
- By:
- Publication type:
- Article
16
No association between chronic cerebrospinal venous insufficiency and pediatric-onset multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2012, v. 18, n. 12, p. 1791, doi. 10.1177/1352458512445943
- By:
- Publication type:
- Article
17
Multiple sclerosis in diverse populations: characteristics in distinct Arab ethnicities in Israel.
- Published in:
- Multiple Sclerosis Journal, 2012, v. 18, n. 12, p. 1737, doi. 10.1177/1352458512445059
- By:
- Publication type:
- Article
18
The effects of clinical interventions on health-related quality of life in multiple sclerosis: a meta-analysis.
- Published in:
- Multiple Sclerosis Journal, 2012, v. 18, n. 12, p. 1686, doi. 10.1177/1352458512445201
- By:
- Publication type:
- Article
19
Acute demyelinating lesions with restricted diffusion in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2012, v. 18, n. 12, p. 1745, doi. 10.1177/1352458512445407
- By:
- Publication type:
- Article
20
Frequent but nonspecific venous narrowing in paediatric multiple sclerosis.
- Published in:
- 2012
- By:
- Publication type:
- Letter
21
Detrimental role of granulocyte-colony stimulating factor in neuromyelitis optica: clinical case and histological evidence.
- Published in:
- 2012
- By:
- Publication type:
- Case Study
22
A pilot study of the immunological effects of high-dose vitamin D in healthy volunteers.
- Published in:
- Multiple Sclerosis Journal, 2012, v. 18, n. 12, p. 1797, doi. 10.1177/1352458512442992
- By:
- Publication type:
- Article
23
Evaluation of the 2010 McDonald multiple sclerosis criteria in children with a clinically isolated syndrome.
- Published in:
- Multiple Sclerosis Journal, 2012, v. 18, n. 12, p. 1768, doi. 10.1177/1352458512444661
- By:
- Publication type:
- Article
24
Oligoclonal band and multiple sclerosis risk in monosymptomatic optic neuritis patients: a retrospective study of 84 patients.
- Published in:
- Multiple Sclerosis Journal, 2012, v. 18, n. 12, p. 1804, doi. 10.1177/1352458512443918
- By:
- Publication type:
- Article
25
Human endogenous retrovirus type W envelope expression in blood and brain cells provides new insights into multiple sclerosis disease.
- Published in:
- Multiple Sclerosis Journal, 2012, v. 18, n. 12, p. 1721, doi. 10.1177/1352458512441381
- By:
- Publication type:
- Article